MT-2 10mg/vial 1 Vial by Bio-Peptide

Usage

1. Gather supplies: Bio-Peptide MT-2 10 mg vial, bacteriostatic water, 29–31 gauge insulin syringes, alcohol swabs, and a sharps disposal container.
2. Reconstitute by injecting 1–2 mL of bacteriostatic water slowly along the inner vial wall using an insulin syringe; swirl gently for 30 seconds until the lyophilised powder dissolves completely — never vortex or shake vigorously.
3. Calculate your dose: with 2 mL reconstitution volume, every 0.1 mL drawn = 0.5 mg MT-2; for a 0.25 mg starting dose, draw 0.05 mL into a fresh syringe.
4. Select a subcutaneous injection site — lower abdomen or outer thigh — swab with an alcohol wipe, allow to air-dry, then pinch the skin and insert the needle at a 45-degree angle; inject slowly and withdraw.
5. Administer your first loading doses in the evening to reduce the likelihood of nausea; plan brief, 10–15 minute outdoor UV exposure during daylight hours the following day to synergise with MC1R melanocyte activation.
6. After each use, recap the vial, label it with the reconstitution date, and store refrigerated at 2–8 °C; use within 4 weeks and inspect for particulates or colour change before every injection — discard if either is observed.

Warnings

Frequently asked questions

How quickly does Melanotan 2 produce a visible tan without sunbeds?

Most users report noticeable pigmentation darkening within 2–4 weeks of daily subcutaneous loading doses of 0.25–0.5 mg, combined with brief, incidental UV exposure such as 10–15 minutes of natural sunlight. Fitzpatrick skin types I–II typically require the longer end of this range. The tan develops gradually as eumelanin production and redistribution increase in dermal melanocytes following MC1R activation.

What effect does Melanotan 2 have on libido and how does that mechanism work?

MT-2 enhances libido by binding MC4R receptors in the hypothalamus, initiating pro-sexual CNS signalling in both sexes. In male subjects, this pathway has been shown to facilitate spontaneous erections independent of arousal stimuli, a finding documented in peer-reviewed pharmacological research since the late 1990s. The effect is typically noticed within the first few days of administration and is considered a predictable pharmacological outcome rather than a side effect.

Can Melanotan 2 suppress appetite, and is that effect dose-dependent?

Yes — MT-2 reduces appetite through hypothalamic MC4R agonism, the same receptor pathway responsible for its libido effects. The appetite-suppressing response appears dose-dependent: users administering doses above 0.5 mg commonly report reduced hunger for several hours post-injection. At standard maintenance doses of 0.25 mg, appetite suppression is mild and transient, making caloric management relatively straightforward during a tanning protocol.

How do you reconstitute and store a 10mg MT-2 vial after opening?

Reconstitute the lyophilised MT-2 powder by injecting 1–2 mL of bacteriostatic water into the vial using a standard insulin syringe, directing the stream along the vial wall to avoid foaming. Swirl gently — never shake. Once reconstituted, store the vial refrigerated at 2–8 °C; it remains stable for up to 4 weeks. Discard any unused solution showing particulate matter or discolouration.

What syringe type is recommended for MT-2 injections and how is the dose measured?

A 29–31 gauge insulin syringe (0.3 mL or 1 mL capacity) is the standard tool for subcutaneous MT-2 administration. With a 2 mL reconstitution volume from a 10 mg vial, each 0.1 mL drawn equals 0.5 mg of MT-2. For a 0.25 mg loading dose, draw 0.05 mL. Injection sites include the abdomen or outer thigh; rotate sites to minimise localised irritation and subcutaneous nodule formation. (2) angle_used

Manufacturer

The foundation of Bio-Peptide's approach to the research-peptide market can be traced to a single, commercially inconvenient constraint its founders chose to build into the company's release process before a single product reached the public: independent laboratory sign-off was mandatory — not aspirational. That constraint meant two specific external checks had to clear for every batch. HPLC (High-Performance Liquid Chromatography) had to confirm the compound's molecular sequence and register an acceptable purity percentage. A separate LAL (Limulus Amebocyte Lysate) endotoxin assay had to certify that bacterial contamination levels fell within injection-grade tolerances. Neither check could be substituted by internal testing, and neither could be waived on logistical or cost grounds. The result is a batch-specific certificate of analysis accompanying every vial — not a generalised quality statement, but a document tied to the exact production run from which that vial originated. This structure was not designed in response to regulatory pressure; it preceded any formal external scrutiny of the European research-compound sector and reflected a founding judgement that the field's credibility problem was, at its core, a verification problem.